| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 6.14e-09 | 5 | 18 | 3 | GO:0004720 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 3.42e-07 | 16 | 18 | 3 | GO:0016641 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 6.94e-07 | 20 | 18 | 3 | GO:0016638 | |
| GeneOntologyMolecularFunction | copper ion binding | 4.49e-05 | 78 | 18 | 3 | GO:0005507 | |
| GeneOntologyMolecularFunction | fibronectin binding | 5.29e-04 | 38 | 18 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | collagen binding | 2.38e-03 | 81 | 18 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 3.31e-03 | 1189 | 18 | 5 | GO:0046914 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine oxidation | 5.57e-09 | 5 | 18 | 3 | GO:0018057 | |
| GeneOntologyBiologicalProcess | protein oxidation | 2.02e-07 | 14 | 18 | 3 | GO:0018158 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.77e-05 | 76 | 18 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation involved in kidney development | 1.22e-04 | 19 | 18 | 2 | GO:2000696 | |
| GeneOntologyBiologicalProcess | regulation of receptor binding | 1.96e-04 | 24 | 18 | 2 | GO:1900120 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.74e-04 | 377 | 18 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.77e-04 | 378 | 18 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.80e-04 | 379 | 18 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 3.56e-04 | 162 | 18 | 3 | GO:0018205 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 7.60e-04 | 47 | 18 | 2 | GO:0035850 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.42e-04 | 530 | 18 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.07e-03 | 656 | 18 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.09e-03 | 658 | 18 | 4 | GO:0030312 | |
| Domain | Lysyl_oxidase | 7.51e-09 | 5 | 18 | 3 | IPR001695 | |
| Domain | Lysyl_oxidase_CS | 7.51e-09 | 5 | 18 | 3 | IPR019828 | |
| Domain | LYSYL_OXIDASE | 7.51e-09 | 5 | 18 | 3 | PS00926 | |
| Domain | Lysyl_oxidase | 7.51e-09 | 5 | 18 | 3 | PF01186 | |
| Domain | SRCR | 1.82e-04 | 21 | 18 | 2 | PF00530 | |
| Domain | SR | 2.60e-04 | 25 | 18 | 2 | SM00202 | |
| Domain | - | 2.60e-04 | 25 | 18 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 2.81e-04 | 26 | 18 | 2 | PS00420 | |
| Domain | SRCR_2 | 2.81e-04 | 26 | 18 | 2 | PS50287 | |
| Domain | SRCR-like_dom | 2.81e-04 | 26 | 18 | 2 | IPR017448 | |
| Domain | SRCR | 3.04e-04 | 27 | 18 | 2 | IPR001190 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.86e-07 | 50 | 15 | 4 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.18e-07 | 61 | 15 | 4 | M27103 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.88e-07 | 18 | 15 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.88e-07 | 18 | 15 | 3 | MM14882 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.02e-06 | 76 | 15 | 4 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.01e-06 | 90 | 15 | 4 | M631 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.71e-06 | 39 | 15 | 3 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.26e-05 | 44 | 15 | 3 | M26969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.28e-04 | 258 | 15 | 4 | MM14572 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 1.42e-04 | 17 | 15 | 2 | M39686 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.28e-04 | 300 | 15 | 4 | M610 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 6.89e-04 | 37 | 15 | 2 | M749 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 8.46e-04 | 41 | 15 | 2 | M512 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.46e-03 | 54 | 15 | 2 | M26911 | |
| Pubmed | 1.38e-09 | 5 | 19 | 3 | 21740577 | ||
| Pubmed | Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. | 7.73e-09 | 8 | 19 | 3 | 19458888 | |
| Pubmed | 1.65e-08 | 10 | 19 | 3 | 23357697 | ||
| Pubmed | Loss of Lysyl Oxidase-like 3 Attenuates Embryonic Lung Development in Mice. | 6.26e-08 | 15 | 19 | 3 | 27645581 | |
| Pubmed | [Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis]. | 8.48e-07 | 3 | 19 | 2 | 22883193 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 19015874 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 25337249 | ||
| Pubmed | Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer. | 8.48e-07 | 3 | 19 | 2 | 30045039 | |
| Pubmed | Differential expression of the LOX family genes in human colorectal adenocarcinomas. | 1.70e-06 | 4 | 19 | 2 | 19724858 | |
| Pubmed | Lysyl oxidases: a novel multifunctional amine oxidase family. | 1.70e-06 | 4 | 19 | 2 | 11642359 | |
| Pubmed | Structural and functional diversity of lysyl oxidase and the LOX-like proteins. | 1.70e-06 | 4 | 19 | 2 | 12686136 | |
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 29758265 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 17287949 | ||
| Pubmed | 1.02e-05 | 9 | 19 | 2 | 26954549 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 3.69e-04 | 52 | 19 | 2 | 30389913 | |
| Coexpression | NABA_ECM_REGULATORS | 1.84e-05 | 238 | 18 | 4 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.96e-05 | 242 | 18 | 4 | MM17062 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | 5.13e-05 | 855 | 18 | 6 | gudmap_developingKidney_e13.5_podocyte cells_1000 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-07 | 193 | 18 | 4 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-07 | 193 | 18 | 4 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-07 | 193 | 18 | 4 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.74e-05 | 148 | 18 | 3 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.74e-05 | 148 | 18 | 3 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.15e-05 | 170 | 18 | 3 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-05 | 172 | 18 | 3 | afa36501d48b1456c511fa0d5d326ec05bdc380f | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.45e-05 | 174 | 18 | 3 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.45e-05 | 174 | 18 | 3 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.45e-05 | 174 | 18 | 3 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.45e-05 | 174 | 18 | 3 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-05 | 175 | 18 | 3 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.68e-05 | 177 | 18 | 3 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.68e-05 | 177 | 18 | 3 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-05 | 181 | 18 | 3 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-05 | 181 | 18 | 3 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-05 | 181 | 18 | 3 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-05 | 181 | 18 | 3 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 183 | 18 | 3 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-05 | 184 | 18 | 3 | 92314fcdb74c0a1262c9334c774819a2a49ba454 | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 5.33e-05 | 185 | 18 | 3 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.59e-05 | 188 | 18 | 3 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.14e-05 | 194 | 18 | 3 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 196 | 18 | 3 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 197 | 18 | 3 | 121ec3f6d978de2f6c2cc397f7327d2e5587ab8b | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.52e-05 | 198 | 18 | 3 | 2591e08e3fbee86ac40f11becd8147d6d39fded6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(MGE-derived_cortical_interneurons--Chandelier_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.05e-04 | 83 | 18 | 2 | e7f7ad1cd8b08172ef2432a80554aa8174a6c675 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(MGE-derived_cortical_interneurons--Chandelier_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.05e-04 | 83 | 18 | 2 | 33fa6e4a01be4d9945b273c884066d4bfdeaa62d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-04 | 103 | 18 | 2 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.65e-04 | 115 | 18 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.65e-04 | 115 | 18 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.65e-04 | 115 | 18 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 119 | 18 | 2 | aa3860c8d25c85baa79a0b6637bce2e269adfcc2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-03 | 130 | 18 | 2 | 1720f16ac06951c3f57b6c3b0944670a571203d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-03 | 130 | 18 | 2 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-03 | 132 | 18 | 2 | 82f312a561d9fdd2ebc2c25926dfc2b333ff0a4f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-03 | 132 | 18 | 2 | fe87cb22e13e17df29ad43327f1aa71361907582 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 136 | 18 | 2 | a2063abe2d7c3277bfbe1514c8c66363cf04b248 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 137 | 18 | 2 | 8e2fa2ef8becace96a68bb85c002329110902fbb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-03 | 142 | 18 | 2 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 1.57e-03 | 147 | 18 | 2 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-03 | 149 | 18 | 2 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-03 | 149 | 18 | 2 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 1.72e-03 | 154 | 18 | 2 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.74e-03 | 155 | 18 | 2 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 158 | 18 | 2 | 2a222301474c4dfd9a776e197c10f4c1cacceb62 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 158 | 18 | 2 | ff9878fd768f22bf2ee4805bac2ba01cb3cb804a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.83e-03 | 159 | 18 | 2 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-03 | 161 | 18 | 2 | d1f2e5245c7c247b684f48f9f877e149a3ee7c06 | |
| ToppCell | lymphoid-B_cell-pro-B|World / Lineage, cell class and subclass | 1.88e-03 | 161 | 18 | 2 | 23138e579f07d5a6f20d41457cb573b4ac95a4ef | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-03 | 162 | 18 | 2 | 40265af9b36fd144a8577b8dacccd4fc0888a593 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-03 | 162 | 18 | 2 | 9522af31f6b2f3cb81b6b84bd08353eea504d1d6 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-03 | 162 | 18 | 2 | 9a18286e361e1dd18e6f943ce27db58b199fb6e4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-03 | 162 | 18 | 2 | 3395e4dffdb9304d157c325e1fc0f12b433c7bd3 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 163 | 18 | 2 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-03 | 164 | 18 | 2 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 164 | 18 | 2 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 164 | 18 | 2 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-03 | 165 | 18 | 2 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-03 | 165 | 18 | 2 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 165 | 18 | 2 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.97e-03 | 165 | 18 | 2 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 165 | 18 | 2 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 165 | 18 | 2 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-03 | 166 | 18 | 2 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-03 | 166 | 18 | 2 | 6fe8db8d45177a78605681f22e04fa8d0594f2df | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-03 | 166 | 18 | 2 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-03 | 166 | 18 | 2 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 166 | 18 | 2 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-03 | 166 | 18 | 2 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-03 | 167 | 18 | 2 | 49d9220f22d10ff06c0512c9c40c26ad51728e4f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-03 | 167 | 18 | 2 | 7ec032a98a13504d15c7e3a4e259278d07f40180 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-03 | 167 | 18 | 2 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-03 | 167 | 18 | 2 | 5e3588eee73693a996bb4846427cf0038ceafbca | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | edbab94f14e16a1a76546a18fe777a183080d1de | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.04e-03 | 168 | 18 | 2 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.04e-03 | 168 | 18 | 2 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 2.04e-03 | 168 | 18 | 2 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.06e-03 | 169 | 18 | 2 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-03 | 169 | 18 | 2 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-03 | 169 | 18 | 2 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-03 | 169 | 18 | 2 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-03 | 170 | 18 | 2 | 489fc97f6002a577b882a8ff3c563b1e42041d38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-03 | 170 | 18 | 2 | 7d736e741799b67a7f022fc6766841c951ef8951 | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 170 | 18 | 2 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 2.09e-03 | 170 | 18 | 2 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 170 | 18 | 2 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.11e-03 | 171 | 18 | 2 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-03 | 171 | 18 | 2 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-03 | 171 | 18 | 2 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-03 | 171 | 18 | 2 | 58bdcbc65062ac09f1c014e08302f938a3e6b252 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-03 | 171 | 18 | 2 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 2.14e-03 | 172 | 18 | 2 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-03 | 172 | 18 | 2 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-03 | 172 | 18 | 2 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.16e-03 | 173 | 18 | 2 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.16e-03 | 173 | 18 | 2 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| Drug | Q 192 | 2.32e-08 | 8 | 18 | 3 | CID000077317 | |
| Drug | NSC55260 | 6.82e-08 | 11 | 18 | 3 | CID005356351 | |
| Drug | BAPN | 2.57e-07 | 71 | 18 | 4 | CID000001647 | |
| Drug | norfenefrine | 3.99e-07 | 19 | 18 | 3 | CID000004538 | |
| Drug | harmaline | 2.44e-06 | 34 | 18 | 3 | CID000022381 | |
| Drug | allylamine | 2.91e-06 | 36 | 18 | 3 | CID000007853 | |
| Drug | AC1O8LBJ | 2.91e-06 | 36 | 18 | 3 | CID005897218 | |
| Drug | EDTA | 3.39e-06 | 135 | 18 | 4 | CID000006049 | |
| Drug | topa quinone | 4.02e-06 | 40 | 18 | 3 | CID000123871 | |
| Drug | amiguanidine | 5.89e-06 | 5 | 18 | 2 | CID000364439 | |
| Drug | semicarbazide | 8.44e-06 | 51 | 18 | 3 | CID000005196 | |
| Drug | 1-benzyl-2-methyl-5-methoxytryptamine | 8.84e-06 | 6 | 18 | 2 | CID000009925 | |
| Drug | BU99006 | 8.84e-06 | 6 | 18 | 2 | CID006603748 | |
| Drug | NSD 2023 | 8.84e-06 | 6 | 18 | 2 | CID000019831 | |
| Drug | 1-PCPA | 8.84e-06 | 6 | 18 | 2 | CID000194548 | |
| Drug | N-cyclopropyl-5,6-dimethoxytryptamine | 8.84e-06 | 6 | 18 | 2 | CID000156277 | |
| Drug | N-cyclopropyl-6,7-dimethoxytryptamine | 8.84e-06 | 6 | 18 | 2 | CID000156278 | |
| Drug | N-cyclopropyl-alpha-methylbenzylamine | 8.84e-06 | 6 | 18 | 2 | CID000362778 | |
| Drug | 5-hydroxyisatin | 8.84e-06 | 6 | 18 | 2 | CID010352011 | |
| Drug | T 794 | 8.84e-06 | 6 | 18 | 2 | CID003077680 | |
| Drug | benzylamine | 8.95e-06 | 52 | 18 | 3 | CID000007504 | |
| Drug | JB 835 | 1.24e-05 | 7 | 18 | 2 | CID000152988 | |
| Drug | 1-benzylcyclopropylamine | 1.24e-05 | 7 | 18 | 2 | CID000152923 | |
| Drug | dimethylphenethylamine | 1.24e-05 | 7 | 18 | 2 | CID000025124 | |
| Drug | BU 224 | 1.24e-05 | 7 | 18 | 2 | CID000002457 | |
| Drug | RS-2232 | 1.24e-05 | 7 | 18 | 2 | CID000134882 | |
| Drug | M 2113 | 1.24e-05 | 7 | 18 | 2 | CID000072895 | |
| Drug | N-(2-aminoethyl)benzamide | 1.24e-05 | 7 | 18 | 2 | CID000423156 | |
| Drug | SR 95191 | 1.24e-05 | 7 | 18 | 2 | CID000072119 | |
| Drug | cimoxatone | 1.24e-05 | 7 | 18 | 2 | CID000052542 | |
| Drug | iproclozide | 1.24e-05 | 7 | 18 | 2 | CID000019063 | |
| Drug | brofaromine | 1.24e-05 | 7 | 18 | 2 | CID000044570 | |
| Drug | p-dimethylaminomethylbenzylamine | 1.24e-05 | 7 | 18 | 2 | CID000193714 | |
| Drug | tetrahydroharmine | 1.24e-05 | 7 | 18 | 2 | CID000159809 | |
| Drug | 4'-amino-MPTP | 1.24e-05 | 7 | 18 | 2 | CID000086263 | |
| Drug | 4-methoxytranylcypromine | 1.24e-05 | 7 | 18 | 2 | CID003082143 | |
| Drug | 1-Phenylcyclobutylamine | 1.24e-05 | 7 | 18 | 2 | CID000152214 | |
| Drug | MPTP-3-ol | 1.24e-05 | 7 | 18 | 2 | CID000100194 | |
| Drug | mofegiline | 1.65e-05 | 8 | 18 | 2 | CID006437850 | |
| Drug | AC1O5VTH | 1.65e-05 | 8 | 18 | 2 | CID006441710 | |
| Drug | pyrazidol | 1.65e-05 | 8 | 18 | 2 | CID000068802 | |
| Drug | 4-fluorotranylcypromine | 1.65e-05 | 8 | 18 | 2 | CID003082666 | |
| Drug | ranbezolid | 1.65e-05 | 8 | 18 | 2 | CID000496993 | |
| Drug | 2-propyl-pentylamine | 1.65e-05 | 8 | 18 | 2 | CID000170419 | |
| Drug | AC1Q6B1A | 1.65e-05 | 8 | 18 | 2 | CID000088562 | |
| Drug | 4-chlorobenzylamine | 1.65e-05 | 8 | 18 | 2 | CID000066036 | |
| Drug | amezinium | 1.65e-05 | 8 | 18 | 2 | CID000071926 | |
| Drug | mebanazine | 1.65e-05 | 8 | 18 | 2 | CID000006179 | |
| Drug | Lilly 51641 | 2.12e-05 | 9 | 18 | 2 | CID000021485 | |
| Drug | pinoline | 2.12e-05 | 9 | 18 | 2 | CID000001868 | |
| Drug | Ro 16-6491 | 2.12e-05 | 9 | 18 | 2 | CID000004289 | |
| Drug | 3-amino-2-oxazolidinone | 2.12e-05 | 9 | 18 | 2 | CID000065725 | |
| Drug | toloxatone | 2.12e-05 | 9 | 18 | 2 | CID000034521 | |
| Drug | MDL 72392 | 2.12e-05 | 9 | 18 | 2 | CID006439254 | |
| Drug | AC1L4KA6 | 2.12e-05 | 9 | 18 | 2 | CID000158620 | |
| Drug | FLA 365 | 2.12e-05 | 9 | 18 | 2 | CID000072776 | |
| Drug | AC1L1BMC | 2.12e-05 | 9 | 18 | 2 | CID000001500 | |
| Drug | FLA 336 | 2.12e-05 | 9 | 18 | 2 | CID000123706 | |
| Drug | J 508 | 2.12e-05 | 9 | 18 | 2 | CID000155219 | |
| Drug | RS-8359 | 2.12e-05 | 9 | 18 | 2 | CID000164116 | |
| Drug | EXP 561 | 2.65e-05 | 10 | 18 | 2 | CID000027696 | |
| Drug | N-cyclopropylbenzylamine | 2.65e-05 | 10 | 18 | 2 | CID000025866 | |
| Drug | U-0521 | 2.65e-05 | 10 | 18 | 2 | CID000021632 | |
| Drug | safrazine | 2.65e-05 | 10 | 18 | 2 | CID000034041 | |
| Drug | NmiQ | 2.65e-05 | 10 | 18 | 2 | CID000019850 | |
| Drug | NSC-169892 | 2.65e-05 | 10 | 18 | 2 | CID000043479 | |
| Drug | acetylcadaverine | 2.65e-05 | 10 | 18 | 2 | CID000189087 | |
| Drug | Monase | 2.65e-05 | 10 | 18 | 2 | CID000008366 | |
| Drug | 3-dimethylamino-1-propyne | 2.65e-05 | 10 | 18 | 2 | CID000081643 | |
| Drug | befloxatone | 3.23e-05 | 11 | 18 | 2 | CID000060824 | |
| Drug | 4-hydroxy-3-methoxyphenylglycol-piperazine | 3.23e-05 | 11 | 18 | 2 | CID002723890 | |
| Drug | Amiflamina | 3.23e-05 | 11 | 18 | 2 | CID000071221 | |
| Drug | fluridone | 3.53e-05 | 82 | 18 | 3 | CID000043079 | |
| Drug | phenylhydrazine | 3.53e-05 | 82 | 18 | 3 | CID000007516 | |
| Drug | FNPA | 3.88e-05 | 12 | 18 | 2 | CID000093121 | |
| Drug | anisylamine | 3.88e-05 | 12 | 18 | 2 | CID000075452 | |
| Drug | HLA20 | 3.88e-05 | 12 | 18 | 2 | CID006918819 | |
| Drug | 2-(2-benzofuranyl)-2-imidazoline | 3.88e-05 | 12 | 18 | 2 | CID003080926 | |
| Drug | AbeAdo | 3.88e-05 | 12 | 18 | 2 | CID006436013 | |
| Drug | tylciprine | 3.88e-05 | 12 | 18 | 2 | CID000026069 | |
| Drug | pheniprazine | 3.88e-05 | 12 | 18 | 2 | CID000005929 | |
| Drug | viloxazine | 3.88e-05 | 12 | 18 | 2 | CID000005666 | |
| Drug | kojic amine | 3.88e-05 | 12 | 18 | 2 | CID000003841 | |
| Drug | MPDP | 3.88e-05 | 12 | 18 | 2 | CID000150458 | |
| Drug | SKF 64139 | 4.58e-05 | 13 | 18 | 2 | CID000123919 | |
| Drug | isocarboxazid | 5.34e-05 | 14 | 18 | 2 | CID000003759 | |
| Drug | benzylhydrazine | 5.34e-05 | 14 | 18 | 2 | CID000011157 | |
| Drug | kynuramine | 5.34e-05 | 14 | 18 | 2 | CID000009692 | |
| Drug | lazabemide | 5.34e-05 | 14 | 18 | 2 | CID000071307 | |
| Drug | 2'CH3-MPTP | 5.34e-05 | 14 | 18 | 2 | CID000091767 | |
| Drug | FMMT | 5.34e-05 | 14 | 18 | 2 | CID006438682 | |
| Drug | Fosinopril | 5.34e-05 | 14 | 18 | 2 | ctd:D017328 | |
| Drug | MDL 72145 | 5.34e-05 | 14 | 18 | 2 | CID006438383 | |
| Drug | pargyline | 5.84e-05 | 97 | 18 | 3 | CID000004688 | |
| Drug | milacemide | 6.16e-05 | 15 | 18 | 2 | CID000053568 | |
| Drug | MFMD | 6.16e-05 | 15 | 18 | 2 | CID000122302 | |
| Drug | butylamino | 6.59e-05 | 101 | 18 | 3 | CID000008007 | |
| Drug | Ro 41-1049 | 7.04e-05 | 16 | 18 | 2 | CID000005086 | |
| Drug | nitecapone | 7.04e-05 | 16 | 18 | 2 | CID005464105 | |
| Drug | methoxytyramine | 7.04e-05 | 16 | 18 | 2 | CID000068384 | |
| Disease | Aortic Aneurysm | 7.37e-06 | 7 | 18 | 2 | C0003486 | |
| Disease | arteriosclerosis (implicated_via_orthology) | 7.37e-06 | 7 | 18 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | abdominal aortic aneurysm (implicated_via_orthology) | 1.26e-05 | 9 | 18 | 2 | DOID:7693 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 1.93e-05 | 11 | 18 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 4.75e-05 | 17 | 18 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | Oral Submucous Fibrosis | 5.35e-05 | 18 | 18 | 2 | C0029172 | |
| Disease | asthma (biomarker_via_orthology) | 5.89e-04 | 59 | 18 | 2 | DOID:2841 (biomarker_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 2.44e-03 | 121 | 18 | 2 | DOID:10763 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 3.25e-03 | 140 | 18 | 2 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.30e-03 | 141 | 18 | 2 | C0005684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEWLWDYEKHGHRHS | 376 | Q8N1M1 | |
| YWEDEDHHPTLHRWF | 156 | P61568 | |
| YEEELLHSHIAHWWS | 231 | Q8N608 | |
| EGDLKWHHHNITYWI | 111 | P14780 | |
| WVWHECHGHYHSMDI | 601 | P58215 | |
| GRDSWVWHQCHRHYH | 601 | Q96JB6 | |
| DISHPAKAWDLHHRW | 376 | Q14123 | |
| DDRSWLEHHVVHQYW | 211 | Q96RT8 | |
| WHEHKHRAKDWCEEL | 791 | A2RRP1 | |
| QDDDMLYWHKHGDGW | 246 | Q9HAP2 | |
| DHHGGDYKHWREWGS | 186 | P05813 | |
| WEWHSCHQHYHSMDE | 286 | P28300 | |
| GRHYWEVEVGDKTHW | 391 | Q9HCM9 | |
| LLYHRASEDWWEGRH | 771 | Q7Z6B7 | |
| SEASEHWEEYLRKWH | 1471 | Q9NTG1 | |
| HQHFEEWHSRWLEDN | 1096 | O75182 | |
| DVVGHHGYHYWRDRW | 486 | Q14940 | |
| YKHWRDSWKLSHVEE | 291 | Q9BVS5 | |
| DVKHHRWFRSVDWEA | 296 | P51817 |